Abstract PD3-05: Inhibition of fatty-acid oxidation as a therapy for triple-negative breast cancer
Andrei Goga(University of California, San Francisco), Nomura DK(University of California, San Francisco), Henok Eyob(University of California, San Francisco), RA Kohnz(University of California, San Francisco), Céline I. Mahieu(University of California, San Francisco), Sanjeev Balakrishnan(University of California, San Francisco), AY Zhou(University of California, San Francisco), Brittany Anderton(Gladstone Institutes), Gregor Krings(Cleveland Clinic), Roman Camarda(University of California, San Francisco)
Cited by 0
Related Papers
Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease
|Nature Microbiology|2019|1k
Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells
|Nature|2015|925
Comprehensive analysis of normal adjacent to tumor transcriptomes
|Nature Communications|2017|663
Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer
|Nature Medicine|2016|539
Mutations in Sarcomere Protein Genes in Left Ventricular Noncompaction
|Circulation|2008|454